创伤后凝血病的血浆蛋白质组特征:与生物力学及患者结局的关联
本研究对创伤患者急诊科到达时采集的血小板贫乏血浆进行蛋白质组学分析,用液相色谱-质谱联用比较健康供者与创伤患者、非严重与严重损伤、存活与死亡、穿透伤与钝性伤、创伤性脑损伤与无脑损伤、有与无生理性休克六组间的蛋白表达差异,并用流变学、浊度和共聚焦显微镜表征凝血。结果显示,纤溶酶原激活物抑制剂3在存活者中丰度高于死亡者,且与更快凝血时间、凝血酶生成和D-二聚体降低相关;死亡者中升高的前列腺素H2异构酶等免疫相关蛋白与较弱血凝块和D-二聚体升高相关。作者认为这些蛋白可能参与凝血病相关死亡并作为治疗靶点。
要点
- 创伤患者急诊到达时血浆中,纤溶酶原激活物抑制剂3在存活者中丰度高于死亡者,且与更快凝血时间、凝血酶生成和D-二聚体降低相关。
- 死亡者中升高的前列腺素H2异构酶等免疫相关蛋白与较弱血凝块和D-二聚体升高相关。
- 止血相关生物学过程在健康供者、严重损伤患者、存活患者、无创伤性脑损伤患者及无休克患者中富集。
- 本研究为探索性血浆蛋白质组分析,识别出与凝血和免疫活动相关的潜在标志物,可能参与创伤后凝血病相关死亡并作为治疗靶点。
适用人群与场景
- 创伤患者,于急诊科到达时采集血小板贫乏血浆。
- 比较组包括:健康供者与创伤患者、非严重损伤与严重损伤、存活与死亡患者、穿透伤与钝性伤、创伤性脑损伤与无创伤性脑损伤、有与无生理性休克。
研究设计与关键结果
- 研究类型为探索性血浆蛋白质组分析;血小板贫乏血浆取自创伤患者急诊科到达时;凝血用流变学、浊度和共聚焦显微镜表征;蛋白质组用液相色谱-质谱联用测定。
- 纤溶酶原激活物抑制剂3在存活者中丰度高于死亡者,且与更快凝血时间、凝血酶生成和D-二聚体降低相关。
- 死亡者中升高的前列腺素H2异构酶等免疫相关蛋白与较弱血凝块和D-二聚体升高相关。
- 止血相关过程在健康供者、严重损伤患者、存活患者、无创伤性脑损伤患者及无休克患者中富集。
证据类型、等级与局限
- 证据类型:探索性血浆蛋白质组分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,所识别的凝血和免疫活动相关标志物可能参与创伤后凝血病相关死亡,并可作为治疗靶点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Traumatic injury is a leading cause of death, in large part driven by coagulopathy-associated hemorrhage and thrombotic complications. Identification of biological pathways and therapeutic targets has been limited. We performed a proteomic analysis using plasma isolated from trauma patients and assessed the proteome relation to clot formation and stability.
METHODS: Platelet-poor plasma was isolated from trauma patients upon emergency department arrival. Coagulation was characterized using rheology, turbidity, and confocal microscopy. Proteomics were measured using liquid chromatography-mass spectrometry and compared between: 1) healthy donors vs . trauma patients, 2) nonsevere vs . severe injury, 3) survived vs . deceased patients, 4) penetrating vs . blunt injuries, 5) traumatic brain injury (TBI) vs . no-TBI, and 6) presence vs . absence of physiological shock. Spearman correlations were calculated between coagulation tests, clinical vitals, and proteomics data. Gene ontology and Search Tool for the Retrieval of Interacting Genes/Proteins analysis identified enrichment of biological processes and interconnectedness of mortality-related proteins.
RESULTS: Hemostatic processes were enriched in healthy donors, severe injury patients, surviving patients, no-TBI patients, and patients not exhibiting shock. Plasminogen activator inhibitor 3 was in higher abundance in those who survived their injuries compared with those who died. Plasminogen activator inhibitor 3 was correlated with faster clotting time, thrombin generation, and decreased D-dimer. Proteins higher in deceased patients compared with those who survived, such as prostaglandin-H2 isomerase, related to immune activity, correlated with weaker clots and increased D-dimer.
CONCLUSIONS: This exploratory analysis of plasma proteomics in trauma patients identified potential markers related to coagulation and immune activity, which may contribute to coagulopathy-associated mortality after injury and serve as therapeutic targets.
参考来源
- Gosselin AR, Parker O, Ali Sinan H, et al. Plasma Proteomic Signatures of Coagulopathy Following Traumatic Injury: Links to Biomechanics and Patient Outcomes. Shock. 2026. PMID: 41770668. doi:10.1097/SHK.0000000000002785
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。